FGF21 and coronary artery disorder: Therefore, we conducted this systematic review and meta-analysis to evaluate the association between FGF21 and CVDs, especially for those closely related to metabolic abnormalities including coronary heart disease (CHD) or coronary artery disease (CAD), atrial fibrillation, cerebral infarction, and hypertension (2).